Inhibition of gp 120-CD4 interaction by various plant extracts

Phytomedicine

Volumn 4, Issue 1, 1997, Pages 53-58

  Woo, E R ^a   Yoon, S H ^a   Kwak, J H ^a   Kim, H J ^a   Park, H ^a  

^a Korea Institute of Science and Technology   (South Korea)

Author keywords

Antiviral agents; CD4+ HeLa cell; gp 120 Cd4 interaction; Human immunodeficiency virus (HIV); Natural products; vPE 16

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; JAPONICA; SEDUM SARMENTOSUM;

EID: 0002386888     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0944-7113(97)80028-1     Document Type: Article

References (20)

1. Boyd. M. R., Hallock, Y. R, Cardellina II, J. H., Manfredi, K. P., Blunt, J. W., McMahon, J. B., Buckheit, R. W., Bringmann, J. G., Schäffer, M., Cragg, G. M., Thomas, D. W., Jato, J. G.: Anti-HIV michellamines from Ancistrocladus korupensis. J. Med. Chem. 37: 1740-1745, 1994.
2. Cheserbo, B., Wehrly, K.: Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity. J. virol. 62: 3779-3788, 1988.
3. Chu, C. K., Schinazi, R. F., Arnold, B. H., Cannon, D. L., Doboszewski, B., Bhadti, V. B., Gu, Z.: Comparative activity of 2',3'-saturated and unsaturated pyrimidine and purine nucleoside against human immunodeficiency virus type 1 in peripheral blood mononuclear cells. Biochem. Pharmacol. 37: 3543-3548, 1988.
4. Clancy, J., Tait-Kamradt, A., Petitaps, J., Manousos, M., McGuirk, P. R., Subashi, T., Watts, P., Wondrack, L.: Assays to detect and characterize human immunodeficiency virus type 1 (HIV-1) receptor antagonists, compounds that inhibit binding of the HIV-1 surface glycoprotein, gp 120 to the CD4 receptor on human T lymphocytes. Antimicrob. Agents Chemother. 38: 2008-2013, 1994.
5. Earl, P. L., Hugin, A. W., Moss, B.: Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenecity of a recombinant vaccinia virus. J. Virol. 64: 2448-2451, 1990.
6. Guo, L., Heinzinfer, N. K., Stevenson, M., Schopfer, L. M., Salhany, J. M.: Inhibition of gp 120-CD4 interaction and human immunodeficiency virus type 1 infection in vitro by pyridoxal 5'-phosphate. Antimicrob. Agents Chemother. 38: 2483-2487, 1994.
7. Harada, S., Koyanagi, Y., Yamamoto, N.: Infection of HTLV-III/LAV in HTLV-I carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229: 563-566, 1985.
8. Levy, J. A., Hoffman, A. D., Kramer, S. M., Landis, J. A., Shimabukuro, J. M.: Isolation of Iymphocytopathic retroviruses from San Francisco patients with AIDS. Science 225: 840-843, 1984.
9. Maddon, P. J., Dalgleish, A. G., McDougal, J. S., Clapham, P. R., Weiss, R. A., Axel, R.: The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell. 47: 333-348, 1986.
10. Matsuzaki, K., Ikeda, H., Ogino, T., Matsumoto, A., Woodruff, H. B., Tanaka, H., Omura, S.: Chloropeptins I and II, novel inhibitors against gp 120-CD4 binding from Streptomyces sp. J. Antibiotics 47: 1173-1174, 1994.
11. Murakami, T., Nakashima, H., Ito, M., Yamamoto, N.: A novel coculture system for evaluating anti-HIV drugs. AIDS 6: 1279-1285, 1992.
12. Nakashima, H., Balzarini, J., Pauwels, R., Baba, M., Schols, D., Desmyter, J., Clercq, E. D.: Anti-HIV-1 activity of antiviral compounds, as quantitated by a focal immunoassay in CD4* HeLa cells and a plaque assay in MT-4 cells. J. Virol. Method. 29: 197-208, 1990.
13. Nakashima, H., Pauwels, R., Baba, M., Schols, D., Desmyter, J., Clercay, E. D.: Tetrazolium-based plaque assay for HIV-1 and HIV-2, and its use in the evaluation of antiviral compounds. J. Virol. Method. 26: 319-330, 1989.
14. Omura, S., Tanaka, H., Matsuzaki, K., Ikeda, H., Masuma, R.: Isochromophilones I and II, novel inhibitors against gp 120-CD4 binding from Penicillium sp. J. Antibiotics 46: 1908-1911, 1993.
15. Otake, T., Miyano, K., Mori, H., Morimoto, M., Ueba, N., Kunita, N., Nakashima, H., Kurimura, T.: Anti-HIV-1 activity of sulfated amphotericin B in vitro. Antiviral Res. 16: 243-266, 1991.
16. Pauwels, R., Balzarini, J., Baba, M., Snoeck, R., Schols, D., Herdewijn, P., Desmyter, J., Clercq, E. D.: Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Method. 20: 309-321, 1988.
17. Popovic, M., Sarngadharan, M. G., Read, E., Gallo, R. C.: Detection isolation and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and Pre-AIDS. Science 224: 497-500, 1984.
18. Sodroski. J., Goh.W.C, Rosen, C., Campbell, K., Haseltine, W. A.: Role of the HTLV-III/LAV envelope in syncytium formation and cytotopathicity. Nature 322: 470-474, 1986.
19. Tan, G. T., Pezzuto, J. M., Kinghorn, A. D., Hughes, S. H.: Evaluation of natural products as inhibitors of human immunodefficiency virus type 1 (HIV-1) reverse transcriptase. J. Nat. Prod. 54: 143-154, 1991.
20. Tochikura, T. S., Nakashima, H., Tanabe, A., Yamamoto, N.: Human immunodeficiency virus (HlV)-induced cell fusion: Quan-tification and its application for the simple and rapid screening of anti-HIV substances in vitro. Virology 164: 542-546, 1988.